v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Gross Sales $ 5,553,738 $ 4,606,796 $ 16,210,701 $ 14,469,698
Total Net Sales 5,553,738 4,606,796 16,210,701 14,469,698
Cost of sales 2,516,204 1,775,709 6,914,955 5,278,638
Gross Profit 3,037,534 2,831,087 9,295,746 9,191,060
Operating expenses 4,168,011 3,735,773 11,513,299 10,667,834
Loss from operations (1,130,477) (904,686) (2,217,553) (1,476,774)
Decrease in fair value of convertible debt 0 0 0 87,380
Interest income, net 3,275 9,414 9,238 28,460
Loss before provision for income taxes (1,127,202) (895,272) (2,208,315) (1,360,934)
Net Loss (1,127,202) (895,272) (2,208,315) (1,360,934)
Preferred dividends 71,031 333,500 191,307 2,334,501
Net Loss attributable to cbdMD, Inc. common shareholders $ (1,198,233) $ (1,228,772) $ (2,399,622) $ (3,695,435)
Net Loss per share:        
Basic and Diluted earnings per share (in dollars per share) $ (0.11) $ (0.21) $ (0.24) $ (1.56)
Weighted average number of shares Basic and Diluted: (in shares) 10,616,617 5,783,354 10,016,121 2,376,157